Drug Profile
Research programme: difluoro anticancer therapeutics - Advanomics
Alternative Names: Adva-33c; Carbon-difluoro derivatives - Advanomics; Carboplatin analogue - Advanomics; Difluoro-CarboplatinLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Advanomics
- Class Fluorinated hydrocarbons; Platinum complexes; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Canada (IV)
- 28 Oct 2010 Preclinical trials in Cancer in Canada (IV)